Search This Blog

Monday, April 8, 2019

Axsome Therapeutics initiated at SVB Leerink

Axsome Therapeutics initiated with an Outperform at SVB Leerink. SVB Leerink analyst Marc Goodman initiated Axsome Therapeutics with an Outperform and $25 price target.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)